Trulieve Q2 revenue $302M, adjusted EBITDA $111M (37% of revenue), net loss $14M

Trulieve Cannabis Corp.

Revenue $302M comparable to prior year; gross margin 61% vs 60% in Q2 2024.
Net loss attributable to common $14M; adjusted net loss $8M excludes non-recurring charges.
Adjusted EBITDA $111M (37% of revenue), up 3% YoY; cash from ops $86M, free cash flow $75M.
Cash at quarter end $401M; sold 12.5M+ branded products (+9% YoY); opened 3 dispensaries.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.